Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Japan Tobacco Inc.
DescriptionOral hypoxia-inducible factor prolyl hydroxylase domain inhibitor (HIF-PHD) inhibitor containing protein
Molecular Target Hypoxia-inducible factor 1 (HIF1)
Mechanism of ActionHypoxia-inducible factor prolyl hydroxylase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAnemia
Indication DetailsTreat anemia in patients with chronic kidney disease (CKD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today